The medications, Mounjaro and copyright, are injectable therapies mostly employed for treating diabetes type 2, but each separate actions. copyright operates by mimicking a natural hormone, GLP-1, to boost insulin release and lower food intake. In contrast, Mounjaro combines GLP-1 effects with a double action, targeting GIP, leading in perhaps enha